Self-Delivery Ternary Bioregulators for Photodynamic Amplified Immunotherapy by Tumor Microenvironment Reprogramming

• Published in: ACS nano Vol. 16; no. 1; pp. 1182 - 1197
• Main Authors: Zhao, Lin-Ping, Zheng, Rong-Rong, Kong, Ren-Jiang, Huang, Chu-Yu, Rao, Xiao-Na, Yang, Ni, Chen, A-Li, Yu, Xi-Yong, Cheng, Hong, Li, Shi-Ying
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 25-01-2022
• Subjects: Cell Line, Tumor; Immunologic Factors - pharmacology; Immunotherapy - methods; Nanoparticles; Photochemotherapy - methods; Photosensitizing Agents - pharmacology; Tumor Microenvironment; reprogramming; self-delivery; tumor microenvironment; photodynamic therapy; immunotherapy
• ISSN: 1936-0851; 1936-086X
• DOI: 10.1021/acsnano.1c08978

Abnormal metabolism of cancer cells results in complex tumor microenvironments (TME), which play a dominant role in tumor metastasis. Herein, self-delivery ternary bioregulators (designated as TerBio) are constructed for photodynamic amplified immunotherapy against colorectal cancer by TME reprogramming. Specifically, carrier-free TerBio are prepared by the self-assembly of chlorine e6, SB505124 (SB), and lonidamine (Lon), which exhibit improved tumor accumulation, tumor penetration, and cellular uptake behaviors. Interestingly, TerBio-mediated photodynamic therapy (PDT) could not only inhibit the primary tumor growth but also induce immunogenic cell death of tumors to activate the cascade immune response. Furthermore, TerBio are capable of TME reprograming by SB-triggered transforming growth factor (TGF)-β blockage and Lon-induced lactic acid efflux inhibition. As a consequence, TerBio significantly suppresses distant and metastatic tumor growth by PDT-amplified immunotherapy. This study might advance the development of self-delivery nanomedicine against malignant tumor growth and metastasis.